MedEdTalks - Primary Care

In this podcast, expert clinicians will discuss multidisciplinary care approaches to consider in tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will cover the symptoms, pathology, causes, and burden of TD, as well as available therapies. 

Transcript: https://tinyurl.com/PrimaryCare3-4

For CME Credit, complete activity here: https://tinyurl.com/PrimaryCare3-4a

In this podcast, expert clinicians will discuss available therapies for tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will cover the symptoms, pathology, causes, and burden of TD, as well as multidisciplinary care approaches to consider.

Transcript: https://tinyurl.com/PrimaryCare3-3

For CME Credit, complete activity here: https://tinyurl.com/PrimaryCare3-3a

In this podcast, expert clinicians will discuss the burden of tardive dyskinesia (TD) on the patient and health care system. TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will cover the symptoms, pathology, and causes of TD, as well as available therapies, and multidisciplinary care approaches to consider.

Transcript: https://tinyurl.com/PrimaryCare3-2

For CME Credit, complete activity here: https://tinyurl.com/PrimaryCare3-2a

In this podcast, expert clinicians will discuss the symptoms, pathology, and causes of tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will cover the burden of TD, as well as available therapies, and multidisciplinary care approaches to consider.

Transcript: https://tinyurl.com/PrimaryCare3-1

For CME Credit, complete activity here: https://tinyurl.com/PrimaryCare3-1a

While the impact of influenza varies, it places a substantial burden on the health of people in the United States  each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the treatment of influenza.

Transcript: https://tinyurl.com/influenza2-5

For CME Credit, complete activity here: https://tinyurl.com/influenza2-5a 

While the impact of influenza varies, it places a substantial burden on the health of people in the United States  each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the treatment of influenza.

Transcript: https://tinyurl.com/influenza2-4

For CME credit, go here: https://tinyurl.com/influenza2-4a 

While the impact of influenza varies, it places a substantial burden on the health of people in the United States  each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the treatment of influenza.

Transcript: https://tinyurl.com/influenza2-3

For CME Credit, complete activity here: https://tinyurl.com/influenza2-3a 

While the impact of influenza varies, it places a substantial burden on the health of people in the United States  each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the prophylaxis of influenza.

Transcript: https://tinyurl.com/influenza2-2

For CME Credit, complete activity here: https://tinyurl.com/influenza2-2a 

While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the diagnosis of influenza.

Transcript: https://tinyurl.com/Influenza2-1

For CME Credit, complete activity here: https://tinyurl.com/influenza2-1a 

While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. 

The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. Peter Dicpinigaitis discuss emerging therapeutic options for the management of patients with refractory chronic cough.

The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. John Russell and Dr. Michael Blaiss discuss the initial steps for the evaluation and management of patients presenting with chronic cough.

The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. John Russell define chronic cough, discuss its symptoms, and review the associated physical and psychological burden of patients with this condition.